Phyllis A. Svingen

4.7k total citations · 1 hit paper
57 papers, 4.0k citations indexed

About

Phyllis A. Svingen is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Phyllis A. Svingen has authored 57 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Molecular Biology, 19 papers in Oncology and 16 papers in Immunology. Recurrent topics in Phyllis A. Svingen's work include Cancer therapeutics and mechanisms (16 papers), Cell death mechanisms and regulation (14 papers) and Immune Cell Function and Interaction (11 papers). Phyllis A. Svingen is often cited by papers focused on Cancer therapeutics and mechanisms (16 papers), Cell death mechanisms and regulation (14 papers) and Immune Cell Function and Interaction (11 papers). Phyllis A. Svingen collaborates with scholars based in United States, United Kingdom and Canada. Phyllis A. Svingen's co-authors include Scott H. Kaufmann, Gregory J. Gores, Maria Eugenia Guicciardi, Hideyuki Miyoshi, Steven F. Bronk, William A. Faubion, Timothy Kottke, Christoph Peters, Jan M. Deussing and Steven D. Gore and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Blood.

In The Last Decade

Phyllis A. Svingen

57 papers receiving 3.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cathepsin B contributes to TNF-α–mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c

2000 606 citations Maria Eugenia Guicciardi, Jan M. Deussing et al. Journal of Clinical Investigation profile →

Peers

Countries citing papers authored by Phyllis A. Svingen

Since Specialization

Citations

This map shows the geographic impact of Phyllis A. Svingen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phyllis A. Svingen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phyllis A. Svingen more than expected).

Fields of papers citing papers by Phyllis A. Svingen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Phyllis A. Svingen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phyllis A. Svingen. The network helps show where Phyllis A. Svingen may publish in the future.

Co-authorship network of co-authors of Phyllis A. Svingen

This figure shows the co-authorship network connecting the top 25 collaborators of Phyllis A. Svingen. A scholar is included among the top collaborators of Phyllis A. Svingen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Phyllis A. Svingen. Phyllis A. Svingen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	BMI1 maintains the Treg epigenomic landscape to prevent inflammatory bowel disease 2021 ·Journal of Clinical Investigation ·(unknown), Adebowale O. Bamidele, Phyllis A. Svingen, (unknown), Thomas C. Smyrk, (unknown), Feda H. Hamdan, Robyn Laura Kosinsky, (unknown), Zhifu Sun, Zhenqing Ye, Asha Nair, Guilherme Piovezani Ramos, Manuel B. Braga Neto, (unknown), Angela Mathison, Steven A. Johnsen, Raúl Urrutia, William A. Faubion	16
2	Disruption of FOXP3–EZH2 Interaction Represents a Pathobiological Mechanism in Intestinal Inflammation 2018 ·Cellular and Molecular Gastroenterology and Hepatology ·Adebowale O. Bamidele, Phyllis A. Svingen, (unknown), Olga F. Sarmento, (unknown), Manuel B. Braga Neto, Subra Kugathasan, Gwen Lomberk, Raúl Urrutia, William A. Faubion	30
3	The Role of the Histone Methyltransferase Enhancer of Zeste Homolog 2 (EZH2) in the Pathobiological Mechanisms Underlying Inflammatory Bowel Disease (IBD) 2016 ·Journal of Biological Chemistry ·Olga F. Sarmento, Phyllis A. Svingen, (unknown), Zhifu Sun, Adebowale O. Bamidele, Angela Mathison, Thomas C. Smyrk, Asha Nair, (unknown), (unknown), Saurabh Baheti, Dermot McGovern, Jessica Friton, Konstantinos A. Papadakis, (unknown), Ramnik J. Xavier, Raúl Urrutia, William A. Faubion	52
4	Stem Cells for Murine Interstitial Cells of Cajal Suppress Cellular Immunity and Colitis Via Prostaglandin E2 Secretion 2015 ·Gastroenterology ·Maneesh Dave, Yujiro Hayashi, Gabriella B. Gajdos, Thomas C. Smyrk, Phyllis A. Svingen, (unknown), Andrea Lörincz, Haidong Dong, William A. Faubion, Tamás Ördög	28
5	Inactivation of the Transcription Factor GLI1 Accelerates Pancreatic Cancer Progression 2014 ·Journal of Biological Chemistry ·Lisa Mills, Lizhi Zhang, Ronald J. Marler, Phyllis A. Svingen, Maite G. Fernández‐Barrena, (unknown), William R. Bamlet, Robert R. McWilliams, Gloria M. Petersen, William A. Faubion, Martín E. Fernández-Zapico	14
6	A Novel Role for Kruppel-like Factor 14 (KLF14) in T-Regulatory Cell Differentiation 2014 ·Cellular and Molecular Gastroenterology and Hepatology ·Olga F. Sarmento, Phyllis A. Svingen, Yuning Xiong, Ramnik J. Xavier, Dermot McGovern, Thomas C. Smyrk, Konstantinos A. Papadakis, Raúl Urrutia, William A. Faubion	31
7	Regulatory T cell kinetics in the peripheral blood of patients with Crohn’s disease 2012 ·Human Immunology ·(unknown), Chetan P. Offord, Sahil Khanna, (unknown), (unknown), Phyllis A. Svingen, Yuning Xiong, Željko Bajzer, William A. Faubion	2
8	The Pathogen Recognition Receptor NOD2 Regulates Human FOXP3+ T Cell Survival 2010 ·The Journal of Immunology ·(unknown), (unknown), Phyllis A. Svingen, Yuning Xiong, Michael P. Bell, Jeanne Tung, Tom Smyrk, (unknown), William A. Faubion	54
9	Immunoblot Analysis and Band Depletion Assays 2003 ·Humana Press eBooks ·Scott H. Kaufmann, Phyllis A. Svingen	18
10	Lack of Correlation between Caspase Activation and Caspase Activity Assays in Paclitaxel-treated MCF-7 Breast Cancer Cells 2002 ·Journal of Biological Chemistry ·Timothy Kottke, April L. Blajeski, X. Wei Meng, Phyllis A. Svingen, Sandrine Ruchaud, Peter W. Mesner, Scott A. Boerner, Kumiko Samejima, (unknown), Tamie J. Chilcote, Janet M. Lord, M Salmon, William C. Earnshaw, Scott H. Kaufmann	64
11	Comparison of potential markers of farnesyltransferase inhibition. 2000 ·PubMed ·Alex A. Adjei, J. Nathan Davis, Charles Erlichman, Phyllis A. Svingen, Scott H. Kaufmann	103
12	A Phase I trial of the farnesyl transferase inhibitor SCH66336: evidence for biological and clinical activity. 2000 ·PubMed ·Alex A. Adjei, Charles Erlichman, J. Nathan Davis, David L. Cutler, Jeff A. Sloan, Randolph S. Marks, Lorelei J. Hanson, Phyllis A. Svingen, Pamela J. Atherton, W. Robert Bishop, Paul T. Kirschmeier, Scott H. Kaufmann	201
13	Cathepsin B contributes to TNF-α–mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c breakdown → 2000 ·Journal of Clinical Investigation ·Maria Eugenia Guicciardi, Jan M. Deussing, Hideyuki Miyoshi, Steven F. Bronk, Phyllis A. Svingen, Christoph Peters, Scott H. Kaufmann, Gregory J. Gores	606
14	Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas 1999 ·Journal of Clinical Investigation ·William A. Faubion, Maria Eugenia Guicciardi, Hideyuki Miyoshi, Steven F. Bronk, Patricia J. Roberts, Phyllis A. Svingen, Scott H. Kaufmann, Gregory J. Gores	446
15	Caspase-mediated Cleavage of DNA Topoisomerase I at Unconventional Sites during Apoptosis 1999 ·Journal of Biological Chemistry ·Kumiko Samejima, Phyllis A. Svingen, Guriqbal S. Basi, Timothy Kottke, Peter W. Mesner, Lance Stewart, Françoise Durrieu, Guy G. Poirier, Emad S. Alnemri, James J. Champoux, Scott H. Kaufmann, William C. Earnshaw	91
16	Effect of adding the topoisomerase I poison 7-ethyl-10-hydroxycamptothecin (SN-38) to 5-fluorouracil and folinic acid in HCT-8 cells: elevated dTTP pools and enhanced cytotoxicity 1998 ·Cancer Chemotherapy and Pharmacology ·Sally A. Mullany, Phyllis A. Svingen, Scott H. Kaufmann, Charles Erlichman	66
17	Activation of Multiple Interleukin-1β Converting Enzyme Homologues in Cytosol and Nuclei of HL-60 Cells during Etoposide-induced Apoptosis 1997 ·Journal of Biological Chemistry ·L. Miguel Martins, Timothy Kottke, Peter W. Mesner, Guriqbal S. Basi, Sukanto Sinha, Normand L. Frigon, (unknown), Jay S. Tung, (unknown), Atsushi Takahashi, Phyllis A. Svingen, Benjamin J. Madden, Daniel McCormick, William C. Earnshaw, Scott H. Kaufmann	198
18	Cytotoxic Effects of Topotecan Combined With Various Anticancer Agents in Human Cancer Cell Lines 1996 ·JNCI Journal of the National Cancer Institute ·Scott H. Kaufmann, David M. Peereboom, (unknown), Phyllis A. Svingen, L B Grochow, Ross C. Donehower, Eric K. Rowinsky	151
19	Factors Affecting Topotecan Sensitivity in Human Leukemia Samples^a 1996 ·Annals of the New York Academy of Sciences ·Scott H. Kaufmann, Steven D. Gore, Louis Letendre, Phyllis A. Svingen, Timothy Kottke, (unknown), Richard J. Jones, Louise B. Grochow, Philip J. Burke, Ross C. Donehower, Eric K. Rowinsky	9
20	Levamisole Potentiation of Fluorouracil Antiproliferative Activity Mimicked by Orthovanadate, an Inhibitor of Tyrosine Phosphatase 1992 ·JNCI Journal of the National Cancer Institute ·J. S. Kovach, Phyllis A. Svingen, Dan Schaid	44

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact